 <h1>Cyclafem 0.5 / 35 Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>ethinyl estradiol / norethindrone</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about ethinyl estradiol / norethindrone. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Cyclafem 0.5 / 35.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to ethinyl estradiol / norethindrone: oral capsule liquid filled, oral tablet, oral tablet chewable</i></p><p>Other dosage forms:</p><ul><li>oral tablet, oral tablet chewable</li></ul><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Junel®, Loestrin®, Microgestin®, Tri-Legest®: Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. This risk increases with age and with heavy smoking (15 or more cigarettes per day) and is quite marked in women over 35 years of age. Women who use oral contraceptives should be strongly advised not to smoke.Femhrt®: Estrogen alone or with a progestin should not be used for the prevention of cardiovascular disease or dementia. Increased risks of stroke, DVT, pulmonary embolism, myocardial infarction, and invasive breast cancer have been reported with estrogen plus progestin therapy. Increased risks of stroke and DVT have been reported with estrogen-alone therapy, along with increased risk for endometrial cancer in a woman with a uterus who uses unopposed estrogens. An increased risk of probable dementia in postmenopausal women aged 65 and older has been reported with estrogen alone and with estrogen plus progestin therapy. Risks should be assumed to be similar for other doses, combinations, and dosage forms of estrogens and progestins. Estrogens with or without progestins should be prescribed at the lowest effective doses and for the shortest duration possible.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, ethinyl estradiol/norethindrone may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking ethinyl estradiol / norethindrone:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Absent, missed, or irregular menstrual periods</li>
<li>anxiety</li>
<li>change in vision</li>
<li>changes in skin color</li>
<li>chest pain or discomfort</li>
<li>chills</li>
<li>clay-colored stools</li>
<li>constipation</li>
<li>cough</li>
<li>dark urine</li>
<li>diarrhea</li>
<li>dizziness or lightheadedness</li>
<li>fainting</li>
<li>fast heartbeat</li>
<li>fever</li>
<li>headache</li>
<li>hives or welts</li>
<li>itching skin</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>loss of appetite</li>
<li>medium to heavy, irregular vaginal bleeding between regular monthly periods, which may require the use of a pad or a tampon</li>
<li>nausea</li>
<li>pain or discomfort in the arms, jaw, back, or neck</li>
<li>pain, tenderness, or swelling of the foot or leg</li>
<li>pains in the chest, groin, or legs, especially in the calves of the legs</li>
<li>pounding in the ears</li>
<li>rash</li>
<li>redness of the skin</li>
<li>severe headaches of sudden onset</li>
<li>slow or fast heartbeat</li>
<li>stomach pain</li>
<li>sudden loss of coordination or slurred speech</li>
<li>sweating</li>
<li>troubled breathing</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
<li>vomiting of blood</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of ethinyl estradiol / norethindrone may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Bloating</li>
<li>blotchy spots on the exposed skin</li>
<li>breast enlargement or tenderness</li>
<li>discouragement</li>
<li>feeling sad or empty</li>
<li>irritability</li>
<li>itching of the vagina or outside genitals</li>
<li>loss of interest or pleasure</li>
<li>pain during sexual intercourse</li>
<li>stomach cramps</li>
<li>thick, white curd-like vaginal discharge without odor or with mild odor</li>
<li>tiredness</li>
<li>trouble concentrating</li>
<li>trouble sleeping</li>
<li>trouble wearing contact lenses</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ethinyl estradiol / norethindrone: oral capsule, oral tablet, oral tablet chewable</i></p><h3>General</h3><p>The most frequently reported side effects were headache, vaginal candidiasis, nausea, menstrual cramps, breast tenderness, abdominal pain, mood changes, bacterial vaginitis, acne, irregular uterine bleeding, and weight gain.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Vaginal candidiasis, menstrual cramps, breast tenderness, bacterial vaginitis, abnormal/irregular bleeding, metrorrhagia, irregular menstruation, menorrhagia, vaginal hemorrhage, breast pain, dysmenorrhea, vaginal hemorrhage, dysfunctional uterine bleeding</p>
<p><b>Frequency not reported</b>: Ovarian vein thrombosis, vaginitis, amenorrhea, breakthrough bleeding, breast enlargement, breast secretion, cervical erosion changed, cervical secretion, menstrual flow changed, diminution in lactation, spotting, temporary infertility after discontinuation of treatment, premenstrual syndrome, uterine fibroid disease exacerbated</p>
<p><b>Postmarketing reports</b>: Vaginal infection, pollakiuria, dysuria, ovarian cyst, pelvic pain, ovarian cyst rupture, pelvic fluid collection, nipple pain, nipple discharge, galactorrhea, fibrocystic breast change, breast disorder, breast mass, uterine leiomyomata size increased, cervical ectropion changed, endometrial hyperplasia, ovarian cyst, uterine enlargement<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Blood pressure increased</p>
<p><b>Frequency not reported</b>: Deep vein thrombosis, myocardial infarction, hypertension, arterial thromboembolism, thrombophlebitis</p>
<p><b>Postmarketing reports</b>: Coronary artery thrombosis, palpitation, tachycardia, angina pectoris, hot flush, heart rate irregular<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea/vomiting, abdominal pain</p>
<p><b>Frequency not reported</b>: Abdominal cramps, bloating, colitis, dyspepsia, inflammatory bowel disease, Crohn's disease, ulcerative colitis, mesenteric thrombosis</p>
<p><b>Postmarketing reports</b>: Constipation, pancreatitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p>
<p><b>Frequency not reported</b>: Migraine, dizziness, cerebral hemorrhage, cerebral thrombosis</p>
<p><b>Postmarketing reports</b>: Loss of consciousness, hyperesthesia, paresthesia, hypoesthesia, somnolence, sensory disturbance, transient ischemic attack, ischemic stroke, chorea, epilepsy exacerbated, dementia, hemiparesis<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Hepatic adenoma, hepatic carcinoma, benign liver tumor</p>
<p><b>Postmarketing reports</b>: Hemangioma of liver, breast cancer, ovarian cancer, endometrial cancer, uterine cancer<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Postmarketing reports</b>: Hypothyroidism, hyperthyroidism<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Mood swing, depression, mood changed, anxiety</p>
<p><b>Frequency not reported</b>: Nervousness</p>
<p><b>Postmarketing reports</b>: Insomnia, suicidal ideation, panic attack, libido changed, homicidal ideation, dissociation, bipolar disorder, mood disturbed, irritability<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Acne</p>
<p><b>Frequency not reported</b>: Hirsutism, loss of scalp hair, melasma, chloasma, erythema multiforme, erythema nodosum, hemorrhagic eruption, photosensitivity, pruritus</p>
<p><b>Postmarketing reports</b>: Alopecia, generalized rash, allergic rash, skin discoloration, urticaria, angioedema, night sweats, angioedema, hirsutism, skin burning sensation, generalized erythema<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Liver disease, gallbladder disease, cholestatic jaundice, Budd-Chiari syndrome</p>
<p><b>Postmarketing reports</b>: Cholelithiasis, cholecystitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Hemolytic uremic syndrome</p>
<p><b>Postmarketing reports</b>: Anemia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Postmarketing reports</b>: Hypersensitivity reaction, anaphylactic/anaphylactoid reaction<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Corneal curvature change/steepening, contact lens intolerance, cataracts, retinal thrombosis</p>
<p><b>Postmarketing reports</b>: Vision blurred, vision impaired, corneal thinning, fungal infection, transient blindness<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Pulmonary embolism</p>
<p><b>Postmarketing reports</b>: Asthma exacerbated, dyspnea<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Leg cramp, backache</p>
<p><b>Postmarketing reports</b>: Myalgia, arthralgia, back pain<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Weight fluctuation</p>
<p><b>Frequency not reported</b>: Tolerance to carbohydrates reduced</p>
<p><b>Postmarketing reports</b>: Appetite increased, appetite decreased, diabetes mellitus, hypoglycemia, hypocalcemia, triglycerides increased, blood glucose abnormal<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Cervical smear abnormal, weight gain, edema</p>
<p><b>Frequency not reported</b>: Fatigue, porphyria, Vitamin B6 deficient</p>
<p><b>Postmarketing reports</b>: Weight decreased, peripheral edema, malaise, chest pain<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Renal function impaired</p>
<p><b>Postmarketing reports</b>: Cystitis-like syndrome<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Femhrt (ethinyl estradiol-norethindrone)" Parke-Davis, Morris Plains, NJ. </p><p id="ref_2">2. "Product Information. Estrostep Fe (ethinyl estradiol-norethindrone)." Parke-Davis, Morris Plains, NJ. </p><p id="ref_3">3. "Product Information. Lo Minastrin Fe (ethinyl estradiol-norethindrone)." Warner Chilcott Laboratories, Rockaway, NJ. </p><p id="ref_4">4. "Product Information. Femcon FE (ethinyl estradiol-norethindrone)." Actavis (formerly Abrika Pharmaceuticals LLP), Sunrise, FL. </p><p id="ref_5">5. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_6">6. "Product Information. Briellyn (ethinyl estradiol-norethindrone)." Glenmark Pharmaceuticals Inc, Princeton, NJ. </p><p id="ref_7">7. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_8">8. "Product Information. Loestrin 24 Fe (ethinyl estradiol-norethindrone)." Warner Chilcott Laboratories, Rockaway, NJ. </p><p id="ref_9">9. "Product Information. Lo Loestrin Fe (ethinyl estradiol-norethindrone)." Warner Chilcott Laboratories, Rockaway, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Cyclafem 0.5 / 35 (ethinyl estradiol / norethindrone)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: contraceptives</li>
</ul>
<h3>Consumer resources</h3>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Lo Loestrin Fe, Loestrin 21 1/20, Taytulla, Blisovi 24 Fe, ... +22 more</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Birth Control</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ethinyl estradiol / norethindrone: oral capsule, oral tablet, oral tablet chewable</i></p><h3>General</h3><p>The most frequently reported side effects were headache, vaginal candidiasis, nausea, menstrual cramps, breast tenderness, abdominal pain, mood changes, bacterial vaginitis, acne, irregular uterine bleeding, and weight gain.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Vaginal candidiasis, menstrual cramps, breast tenderness, bacterial vaginitis, abnormal/irregular bleeding, metrorrhagia, irregular menstruation, menorrhagia, vaginal hemorrhage, breast pain, dysmenorrhea, vaginal hemorrhage, dysfunctional uterine bleeding</p><p><b>Frequency not reported</b>: Ovarian vein thrombosis, vaginitis, amenorrhea, breakthrough bleeding, breast enlargement, breast secretion, cervical erosion changed, cervical secretion, menstrual flow changed, diminution in lactation, spotting, temporary infertility after discontinuation of treatment, premenstrual syndrome, uterine fibroid disease exacerbated</p><p><b>Postmarketing reports</b>: Vaginal infection, pollakiuria, dysuria, ovarian cyst, pelvic pain, ovarian cyst rupture, pelvic fluid collection, nipple pain, nipple discharge, galactorrhea, fibrocystic breast change, breast disorder, breast mass, uterine leiomyomata size increased, cervical ectropion changed, endometrial hyperplasia, ovarian cyst, uterine enlargement<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Blood pressure increased</p><p><b>Frequency not reported</b>: Deep vein thrombosis, myocardial infarction, hypertension, arterial thromboembolism, thrombophlebitis</p><p><b>Postmarketing reports</b>: Coronary artery thrombosis, palpitation, tachycardia, angina pectoris, hot flush, heart rate irregular<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea/vomiting, abdominal pain</p><p><b>Frequency not reported</b>: Abdominal cramps, bloating, colitis, dyspepsia, inflammatory bowel disease, Crohn's disease, ulcerative colitis, mesenteric thrombosis</p><p><b>Postmarketing reports</b>: Constipation, pancreatitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p><p><b>Frequency not reported</b>: Migraine, dizziness, cerebral hemorrhage, cerebral thrombosis</p><p><b>Postmarketing reports</b>: Loss of consciousness, hyperesthesia, paresthesia, hypoesthesia, somnolence, sensory disturbance, transient ischemic attack, ischemic stroke, chorea, epilepsy exacerbated, dementia, hemiparesis<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Hepatic adenoma, hepatic carcinoma, benign liver tumor</p><p><b>Postmarketing reports</b>: Hemangioma of liver, breast cancer, ovarian cancer, endometrial cancer, uterine cancer<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Postmarketing reports</b>: Hypothyroidism, hyperthyroidism<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Mood swing, depression, mood changed, anxiety</p><p><b>Frequency not reported</b>: Nervousness</p><p><b>Postmarketing reports</b>: Insomnia, suicidal ideation, panic attack, libido changed, homicidal ideation, dissociation, bipolar disorder, mood disturbed, irritability<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Acne</p><p><b>Frequency not reported</b>: Hirsutism, loss of scalp hair, melasma, chloasma, erythema multiforme, erythema nodosum, hemorrhagic eruption, photosensitivity, pruritus</p><p><b>Postmarketing reports</b>: Alopecia, generalized rash, allergic rash, skin discoloration, urticaria, angioedema, night sweats, angioedema, hirsutism, skin burning sensation, generalized erythema<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Liver disease, gallbladder disease, cholestatic jaundice, Budd-Chiari syndrome</p><p><b>Postmarketing reports</b>: Cholelithiasis, cholecystitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Hemolytic uremic syndrome</p><p><b>Postmarketing reports</b>: Anemia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Postmarketing reports</b>: Hypersensitivity reaction, anaphylactic/anaphylactoid reaction<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Corneal curvature change/steepening, contact lens intolerance, cataracts, retinal thrombosis</p><p><b>Postmarketing reports</b>: Vision blurred, vision impaired, corneal thinning, fungal infection, transient blindness<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Pulmonary embolism</p><p><b>Postmarketing reports</b>: Asthma exacerbated, dyspnea<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Leg cramp, backache</p><p><b>Postmarketing reports</b>: Myalgia, arthralgia, back pain<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Weight fluctuation</p><p><b>Frequency not reported</b>: Tolerance to carbohydrates reduced</p><p><b>Postmarketing reports</b>: Appetite increased, appetite decreased, diabetes mellitus, hypoglycemia, hypocalcemia, triglycerides increased, blood glucose abnormal<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Cervical smear abnormal, weight gain, edema</p><p><b>Frequency not reported</b>: Fatigue, porphyria, Vitamin B6 deficient</p><p><b>Postmarketing reports</b>: Weight decreased, peripheral edema, malaise, chest pain<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Renal function impaired</p><p><b>Postmarketing reports</b>: Cystitis-like syndrome<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Femhrt (ethinyl estradiol-norethindrone)" Parke-Davis, Morris Plains, NJ. </p><p id="ref_2">2. "Product Information. Estrostep Fe (ethinyl estradiol-norethindrone)." Parke-Davis, Morris Plains, NJ. </p><p id="ref_3">3. "Product Information. Lo Minastrin Fe (ethinyl estradiol-norethindrone)." Warner Chilcott Laboratories, Rockaway, NJ. </p><p id="ref_4">4. "Product Information. Femcon FE (ethinyl estradiol-norethindrone)." Actavis (formerly Abrika Pharmaceuticals LLP), Sunrise, FL. </p><p id="ref_5">5. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_6">6. "Product Information. Briellyn (ethinyl estradiol-norethindrone)." Glenmark Pharmaceuticals Inc, Princeton, NJ. </p><p id="ref_7">7. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_8">8. "Product Information. Loestrin 24 Fe (ethinyl estradiol-norethindrone)." Warner Chilcott Laboratories, Rockaway, NJ. </p><p id="ref_9">9. "Product Information. Lo Loestrin Fe (ethinyl estradiol-norethindrone)." Warner Chilcott Laboratories, Rockaway, NJ. </p><h2>More about Cyclafem 0.5 / 35 (ethinyl estradiol / norethindrone)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: contraceptives</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Birth Control</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>